Gravesâ?? disease is the most common cause of hyperthyroidism. Adequate\nmanagement is an area of controversy, especially when it comes to children.\nThe objective of our study was to assess the outcome of Gravesâ?? disease\ntreatment in Albert Royer Children Hospital of Dakar. This was a retrospective\nstudy conducted from 2001 to 2015, and which involved all children between\n0 to 15 years of age who were being monitored in the Albert Royer National\nChildren Hospital. The evolutionary modalities were: stability, remission,\nfailure, relapse, lost to follow-up and death. The data were analyzed with\nSPSS software version 20.0. For the comparisons, the KHI 2 or Fisher test was\nused with a significance threshold (p < 0.05). During the study period, 88\nchildren were enrolled. The average age was 8.6 years [ranging from 8\nmonths to 15 years]. The consultation delay was 11.36 months. In our study,\n61.4% of the patients were regular in the follow-up, the observance was good\nin 40.9% of the cases and 19 patients (21.6%) were lost to follow-up. Clinical\ncourses of 69 children after treatment with Carbimazole for 37 months were\npromising in 21 cases (30.43%), with 17 cases of remission (24.63%) and 4\ncases of stability (5.8%). Age older than 10, the initial ATD dose greater than\n1 mg/kg/day and the initial free T4 lower than 50 pmol/l were significantly\nassociated with remission with a p value of 0.01; 0.024 and 0.004.
Loading....